Group FH ORTHO has launched in the United States its new round baseplate for reverse shoulder prostheses.

The JARVIS system is dedicated to reverse glenoid indications and is designed to offer a wide range of lateralization, medialization, and distalization, with optimal fixation through its features. It includes options for compression and locking screws, as well as compatibility with both standard and eccentric glenospheres.

“This launch represents a significant milestone in enhancing shoulder joint replacement solutions for American patients,” said FH ORTHO Director Emmanuel Fradier, vice president of Extremities, Trauma & Sports Medicine.

Key JARVIS features include:

• A normal and augmented round baseplate: Available in 10°-, 20°-, and 30°- angles, the product provides increased flexibility for surgeons. Central screw and long peg options, in addition to the four compression or locking peripheral screws, ensure the baseplate’s stability.
• An adaptive Glenosphere: Offers three different lateralization rates and several eccentric versions for distalization. A central Morse taper ensures the glenosphere’s fixation to the baseplate.
• Compatibility: JARVIS is compatible with Arrow Prime and Short Stem for the humeral side.
• High-quality materials: Manufactured from UHMWPE, Ti6Al4V, cobalt chromium, and porous coating for maximum durability and biocompatibility.
• Development and innovation: The JARVIS program has been developed with a focus on precision and user-friendliness for surgeons. The glenoid build is designed to accommodate different rates of lateralization and distalization, tailored to meet the patient’s condition.

The new JARVIS round baseplate will be available in the United States this month.

After gaining U.S. Food and Drug Administration (FDA) clearance for the Short Stem in June 2022, Group FH ORTHO received FDA clearance for JARVIS in November 2024.

For more than 60 years, Group FH Ortho has demonstrated passionate dedication to creating innovative implants, evaluating them, and following them clinically. The company promotes original products and techniques designed in collaboration with expert surgeons, distributes products worldwide from its ISO 9001/13485-certified distribution site, and provides unparalleled service that guarantees the confidence and loyalty of healthcare facilities.

Group FH Ortho designs, manufactures, and distributes orthopedic implants and instruments in France and beyond. With two operations in France and two subsidiaries in the United States and Poland, Group FH Ortho and its partners work together to offer services and products that ensure patient safety.